Cellectar Biosciences competitorsClear all

Cellectar Biosciences's top competitors include Therapeia, ImmunoCellular Therapeutics, Tetherex and Sanochemia Pharmazeutika.
Cellectar Biosciences
Cellectar Biosciences
Cellectar Biosciences is a clinical stage biopharmaceutical company that engages in the development of targeted phospholipid drug conjugates for the treatment and imaging of cancer.
Therapeia
Therapeia
Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
Tetherex
Tetherex
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika
Sanochemia Pharmazeutika is a specialty pharmaceuticals company, which develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology.
Founding Date
Founding Date
1996
Founding Date
2007
Founding Date
2006
Founding Date
2014
Founding Date
1990
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Madison, US HQ
Florham Park, US
Locations
Dresden, DE HQ
Locations
Calabasas, US HQ
Locations
Oklahoma City, US HQ
Morrisville, US
Locations
Wien, AT HQ
Neufeld An Der Leitha, AT
Neuss, DE
Zug, CH
City Of Bristol, GB
Charlotte, US
Employees
Employees
753% decrease
Employees
N/A
Employees
357% decrease
Employees
N/A
Employees
152
Valuation ($)
Valuation ($)
32.7 m
Valuation ($)
N/A
Valuation ($)
1.2 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
494
Twitter followers
N/A
Twitter followers
620
Twitter followers
N/A
Twitter followers
N/A

Financial

Net income
Net income
($14.1m) (FY, 2019)
Net income
N/A
Net income
($14.3m) (FY, 2017)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 32.5m
Total funding raised
$ 46.2m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Therapeia
HQ
Dresden, DE

Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.

View company
ImmunoCellular Therapeutics
HQ
Calabasas, US
Employees
3

ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.

View company
Tetherex
HQ
Oklahoma City, US

Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.

View company
Sanochemia Pharmazeutika
HQ
Wien, AT
Employees
152

Sanochemia Pharmazeutika is a specialty pharmaceuticals company, which develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology.

View company